Core-binding Factor Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Core-binding Factor Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MyeloMATCH Treatment Trial) [Phase 2]
Phase 2 MyeloMATCH trial evaluating adding venetoclax or gemtuzumab ozogamicin to the 7+3 regimen for core-binding factor acute myeloid leuk…
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation [Phase 2]
This notice describes a Phase 2 clinical trial evaluating avapritinib for relapsed or refractory pediatric core-binding factor acute myeloid…